Who are the key players in Microcarrier Market?

Thermo Fisher Scientific, Merck KGaA, Eppendorf AG, Danaher Corporation and Sartorius AG are the major companies operating in the Microcarrier Market. Read More

Which is the fastest growing region in Microcarrier Market?

North America is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Microcarrier Market?

In 2024, the Asia Pacific accounts for the largest market share in Microcarrier Market. Read More

What years does this Microcarrier Market cover, and what was the market size in 2023?

In 2023, the Microcarrier Market size was estimated at USD 1.92 billion. The report covers the Microcarrier Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Microcarrier Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Microcarrier Market Size

Market Size of Microcarrier Industry

Study Period	2019 - 2029
Market Size (2024)	USD 2.03 Billion
Market Size (2029)	USD 2.70 Billion
CAGR (2024 - 2029)	5.82 %
Fastest Growing Market	North America
Largest Market	Asia Pacific
Major Players *Disclaimer: Major Players sorted in no particular order

Microcarrier Market Analysis

The Microcarrier Market size is estimated at USD 2.03 billion in 2024, and is expected to reach USD 2.70 billion by 2029, growing at a CAGR of 5.82% during the forecast period (2024-2029).

The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research.

Many of the current biologics in the pipeline are targeting the indications, which are small-molecule dominated and have a large patient pool. This represents that in the forecast period the trend of biologics could enter several of the non-traditional biologic disease areas, which could benefit from the increased therapeutic efficacy. Furthermore, this is also providing the room to the biosimilar market to grow.

In terms of medical efficacy, therapeutic spread, and population access biopharmaceuticals have vast potential, and much of this potential is still untapped. This potential can gradually be realized as manufacturing technologies, such as microcarrier based synthesis make progress, which may lead to commercialization of more effective therapies, increased manufacturing efficacy, and reduced therapy costs. Hence, owing to such rapid growth of the biologics and biosimilar industry, the market is positively affected.

Microcarrier Industry Segmentation

A microcarrier is a support matrix, which allows the growth of adherent cells in bioreactors. In the large-scale commercial production of biologics and vaccines, microcarriers are employed to grow virus-generating or protein-producing adherent cell populations. As per the scope of the report, the microcarrier market includes various equipment and consumables, such as bioreactors, reagents, cell counters, and culture vessels in addition to microcarrier beads.

By Material Type
		Alginate-Based
		Collagen-Based
		Dextran-Based
		Polystyrene-Based
		Others

By Application
		Cell Therapy
		Vaccine Manufacturing
		Other Applications

Geography

North America
	United States
	Canada
	Mexico

Europe
	Germany
	United Kingdom
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East and Africa
	GCC
	South Africa
	Rest of Middle East and Africa

South America
	Brazil
	Argentina
	Rest of South America

Need A Different Region Or Segment?

Customize Now

Microcarrier Market Size Summary

The microcarrier market is poised for significant growth, driven by the increasing demand for cell-based vaccines and therapeutics, alongside the rapid expansion of the biologics and biosimilar industry. This growth is further supported by heightened research and development activities and the availability of funding for cell therapy research. The market is witnessing a shift as biologics begin to target non-traditional disease areas, enhancing therapeutic efficacy and expanding the biosimilar market. Microcarriers play a crucial role in this landscape by facilitating cost-effective cell production, which is essential for large-scale manufacturing. Technological advancements, such as the development of dissolvable microcarriers, are enhancing the efficiency of cell therapy applications, thereby reducing production costs and streamlining downstream processes.

North America is expected to hold the largest share of the microcarrier market, driven by robust gene and cell therapy research and supportive associations like the American Society of Gene and Cell Therapy. The region's growth is further bolstered by the rapid advancement of the biologics and biosimilar industry, particularly in the United States. The market is characterized by the presence of global players such as Thermo Fisher Scientific, Sartorius AG, Eppendorf AG, Danaher Corporation, and Merck KGaA, with increasing competition as new entrants emerge. These companies are focusing on providing microcarriers that enable large-scale and cost-effective production, which is crucial for the continued expansion of cell therapy applications.

Explore More

Microcarrier Market Size - Table of Contents

1. MARKET DYNAMICS
1. 1.1 Market Overview
2. 1.2 Market Drivers
  1. 1.2.1 Rising Demand for Cell-based Vaccines and Therapeutics
  2. 1.2.2 Rapid Growth of Biologics and Biosimilar Industry
  3. 1.2.3 Increasing R&D and Availability of Funding for Cell Therapy Research
3. 1.3 Market Restraints
  1. 1.3.1 High Cost of Biologics and Cell-based Therapies
  2. 1.3.2 Possible Drawbacks of Microcarrier Cultures
4. 1.4 Porter's Five Force Analysis
  1. 1.4.1 Threat of New Entrants
  2. 1.4.2 Bargaining Power of Buyers/Consumers
  3. 1.4.3 Bargaining Power of Suppliers
  4. 1.4.4 Threat of Substitute Products
  5. 1.4.5 Intensity of Competitive Rivalry
2. MARKET SEGMENTATION
1. 2.1 By Material Type
  1. 2.1.1 Alginate-Based
  2. 2.1.2 Collagen-Based
  3. 2.1.3 Dextran-Based
  4. 2.1.4 Polystyrene-Based
  5. 2.1.5 Others
2. 2.2 By Application
  1. 2.2.1 Cell Therapy
  2. 2.2.2 Vaccine Manufacturing
  3. 2.2.3 Other Applications
3. 2.3 Geography
  1. 2.3.1 North America
    1. 2.3.1.1 United States
    2. 2.3.1.2 Canada
    3. 2.3.1.3 Mexico
  2. 2.3.2 Europe
    1. 2.3.2.1 Germany
    2. 2.3.2.2 United Kingdom
    3. 2.3.2.3 France
    4. 2.3.2.4 Italy
    5. 2.3.2.5 Spain
    6. 2.3.2.6 Rest of Europe
  3. 2.3.3 Asia-Pacific
    1. 2.3.3.1 China
    2. 2.3.3.2 Japan
    3. 2.3.3.3 India
    4. 2.3.3.4 Australia
    5. 2.3.3.5 South Korea
    6. 2.3.3.6 Rest of Asia-Pacific
  4. 2.3.4 Middle East and Africa
    1. 2.3.4.1 GCC
    2. 2.3.4.2 South Africa
    3. 2.3.4.3 Rest of Middle East and Africa
  5. 2.3.5 South America
    1. 2.3.5.1 Brazil
    2. 2.3.5.2 Argentina
    3. 2.3.5.3 Rest of South America